entertainment -WSS

entertainment

author：knowledge 2025-09-06 04:50:45 - browse：1

Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial.

The negative outcome of the Phase 3 study represents a setback in the company’s efforts to expand the use of Nuplazid into the treatment of schizophrenia. The medicine is currently approved to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

“We are disappointed the trial did not meet its primary endpoint given the significant unmet need in patients with negative symptoms of schizophrenia,” said Acadia CEO Steve Davis, in a statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Medicare Advantage 2025 payments will dip, Biden administration says

focus

WSS

Medical leaders decry Supreme Court decision on affirmative action

Pancreatic cancer is often deadly, but new discoveries are raising hope

Study: Black kids more likely to die after surgery than white kids

Duchenne breakthrough therapy leaves behind pioneering families

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Overprescribed: High cost isn't America's only drug problem

focus

entertainment

explore

Moonlake's readout produced a cash windfall. Risks remain

Scientific mystery highlights the blind spots in genomics databases

How to save PrEP access — and even expand it

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Anesthesiologist group: stop taking Ozempic before surgery

Hundreds died while taking an arthritis drug, but nobody alerted patients

Dobbs anniversary: the lost opportunity of abortion as health care

Study: Black kids more likely to die after surgery than white kids

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The high cost of giving birth even with insurance

hotspot

U.K. decision on ALS drug has neurologists, advocates up in arms

Four alarming medical procedures we’re glad history forgot

Overprescribed: High cost isn't America's only drug problem

Florida Supreme Court upholds state's abortion ban

State Dept. review finds Biden bears some blame for Afghanistan failures

Malaria cases in Florida and Texas: Here’s what you need to know

hotspot

focus

focus

focus